The global anxiety and panic disorders drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anxiety disorders are associated with the post-traumatic stress disorder (PTSD), phobias, and obsessive-compulsive disorder. Anxiety and panic disorders correspond with a high burden of illness as they are psychiatric disorders. Attributed to the increasing cases of anxiety disorders, there is a need for the development of novel drugs for its effective treatment. This is likely to drive the growth of the market during the forecast period. Another key trend observed in the market includes the growing prevalence of anxiety and panic disorders in the developed countries, such as the US. Based on diagnostic interview data from National Comorbidity Survey Replication, an estimated 4.7% of US adults experience panic disorder at some time in their lives.
To Request a Sample of our Report on Anxiety and Panic Disorders Drugs Market: https://www.omrglobal.com/request-sample/anxiety-and-panic-disorders-drugs-market
This is further backed by the growing sedentary lifestyle in the developed countries, high disposable income, and increased per capita healthcare expenditure. All these factors are positively influencing the demand for anxiety and panic disorders drugs in such countries. Additionally, various reimbursement policies offered in developed countries for therapies and medication influences the market positively. At present, the two types of drugs available in the market can be largely segmented into antidepressant drugs, and anxiolytic drugs. Of the two, the antidepressant drugs could gross maximum revenue in the next couple of years on the back of the launch of newer selective serotonin reuptake inhibitor (SSRIs) with safer side effects.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Drug Class
• Regions covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape: Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Anxiety and Panic Disorders Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anxiety-and-panic-disorders-drugs-market
Global Anxiety and Panic Disorders Drugs Market Report by Segment
By Drug Class
• Antidepressant Drugs
• Anxiolytic Drugs
Global Anxiety and Panic Disorders Drugs Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
